Home › Therapeutic areas › Metabolic › Phenylketonuria
Phenylketonuria (4 companies)
Companies with an active program in Phenylketonuria.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals | HematologyMetabolic Rare | 1 | Approved | $1.76B | 7 |
| BEAM | Beam Therapeutics | HematologyMetabolic+1 Rare | 1 | Phase 2 | $2.73B | 6 |
| ETON | Eton Pharmaceuticals | GI/HepatologyInfectious Disease+3 Rare | 1 | Approved | $1.63B | 17 |
| MAZE | Maze Therapeutics | MetabolicRenal Rare | 1 | Phase 2 | $1.90B | 4 |
No companies match.